Family Dollar Anti-Diarrheal Products Recalled for Improper Storage Conditions
Family Dollar Stores has recalled specific loperamide anti-diarrheal products distributed between April 30 and June 10, 2022, due to improper storage temperature conditions. Consumers should discontinue use and return affected products.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II FDA recall with no reported illnesses or injuries and no confirmed health impact. The hazard is a CGMP deviation for improper storage temperature, making this a precautionary recall that qualifies as Moderate per the rubric.
Plain-English summary
Family Dollar Stores has recalled three anti-diarrheal medication products due to improper storage temperature conditions. The products were held outside appropriate storage temperature ranges, which constitutes a Current Good Manufacturing Practice (CGMP) violation.
The recalled products are: - GS Anti Diarrheal Loperamide Caplet, 12 count (SKU 915632) - Imodium AD Mint, 4 fluid ounces (SKU 902080) - Imodium AD Caplet, 6 count (SKU 915628)
These products were distributed to Family Dollar Stores nationwide between April 30, 2022, and June 10, 2022.
Consumers who have purchased these products should stop using them immediately and return them to the Family Dollar Store where they were purchased. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- GS ANTI DIARRHEAL LOPERAMIDE CAPLET 12 CT SKU 915632 IMODIUM AD MINT 4 OZ SKU 902080 IMODIUM AD CAPLET 6 CT SKU 915628 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 915632
- 902080
- 915628
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27